Only a couple of months ago, Sensei Biotherapeutics was laying off staff and mulling winding down the company. But the biotech has found a new lease on life—and a new lead drug—via a merger with Faeth Therapeutics.
Morbi et tellus imperdiet, aliquam nulla sed, dapibus erat. Aenean dapibus sem non purus venenatis vulputate. Donec accumsan eleifend blandit. Nullam auctor ligula
Only a couple of months ago, Sensei Biotherapeutics was laying off staff and mulling winding down the company. But the biotech has found a new lease on life—and a new lead drug—via a merger with Faeth Therapeutics.